REG - Craneware plc - Craneware forms Alliance with Microsoft

CranewareAnnouncement

02/07/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240702:nRSB7007Ua&default-theme=true

RNS Number : 7007U  Craneware plc  02 July 2024

Craneware plc

("Craneware", "The Craneware Group", the "Company" or the "Group")

Craneware forms Alliance with Microsoft to further transform the business of
healthcare

Craneware named a Microsoft Global Partner Solution provider and agrees to
joint go-to-market plan for its Trisus offerings

2 July 2024 - Craneware (AIM: CRW.L), the market leader in value cycle
solutions for the U.S. healthcare market, is pleased to announce that it has
signed agreements with Microsoft in the areas of the Microsoft Azure cloud
platform, technical innovation, and healthcare industry collaboration,
including joint marketing initiatives. The collaboration will see the delivery
of differentiated offerings and increased value to customers through the
application of industry leading data analytics, AI, and modern platform
technology. As part of the agreement, Craneware's Trisus Platform and select
Trisus offerings will be available on the Azure Marketplace. Craneware has
also signed a Microsoft Azure Consumption Commitment (MACC) agreement.

 

Strategic Highlights:

 

 ·             Accelerated innovation of The Craneware Group's solutions utilising Microsoft
               Azure's advanced tools and services
 ·             Ease of access for healthcare customers to purchase the Trisus Platform and
               products via the marketplace, pre-configured and ready to deploy on Microsoft
               Azure
 ·             A proactive go-to-market plan, including joint marketing initiatives
 ·             Expanded cloud capabilities through access to additional advanced features of
               the Microsoft Azure cloud platform
 ·             Predictable cloud spending, budget optimisation, and enhanced financial
               planning, thus driving cost efficiency through the MACC agreement

Craneware teams have begun co-innovation with Microsoft's AI experts to
accelerate the application of AI enhancements to existing Trisus offerings and
the exploration of new AI-based applications. Craneware's long heritage in the
U.S. healthcare industry, as well as nearly 200 million unique patient
encounters within its datasets, mean it is uniquely positioned to provide
powerful, actionable insights to participants across the healthcare industry.
These insights support better operational and strategic decisions, enabling
further efficiencies in provider performance so they can focus on serving
their communities and healthcare missions, transforming the business of
healthcare.

The first of the Trisus applications to be made available on the Microsoft
commercial marketplace in July 2024 will be Trisus Chargemaster, Trisus
Decision Support, and Trisus Labor Productivity. These offerings, supported by
joint go-to-market initiatives and other activities will help expand The
Craneware Group's market reach via the Microsoft partner ecosystem.

Keith Neilson, CEO and Co-Founder at The Craneware Group, commented, "We are
delighted to strengthen our relationship with Microsoft and their Global
Partner Solutions team, with the aim of bringing powerful AI offerings to the
U.S. healthcare industry. This agreement deepens our relationship with
Microsoft, aligning strategic goals and fostering collaboration on future
technology initiatives, marking a milestone in our journey to transform the
business of healthcare."

"By combining the power of Microsoft Azure and its AI capabilities with
Craneware's innovative healthcare revenue integrity solutions, we're thrilled
to be able to support Craneware in not only elevating healthcare providers'
operational efficiency and financial performance, but also enhancing the
quality of patient care," said Gareth Hall, senior director, Health & Life
Sciences, Microsoft. "Together, we can bring advanced AI-powered solutions to
market that will help healthcare customers transform their businesses, deliver
impactful solutions, and demonstrate the additional power of the Microsoft
Cloud for Healthcare."

 

For further information, please contact:

 

 Craneware plc                                    +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma Strategic Communications                    +44 (0)20 3405 0205
 Caroline Forde, Joe Pederzolli, Kinvara Verdon   craneware@almastrategic.com

 Peel Hunt (NOMAD and Joint Broker)               +44 (0)20 7418 8900
 Neil Patel, Benjamin Cryer, Kate Bannatyne

 Investec Bank PLC (Joint Broker)                 +44 (0)20 7597 5970
 Patrick Robb, Henry Reast, Cameron MacRitchie
 ( )
 Berenberg (Joint Broker)                         +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), is the market leader in value cycle
solutions. For 25 years, we have collaborated with U.S. healthcare providers
to optimize revenue integrity, pricing intelligence, decision support, labor
productivity, business of pharmacy, and 340B program management. 

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified,
SaaS-platform, to achieve operational and financial excellence in pursuit of
their healthcare mission - delivering quality care to their communities. The
Craneware Group - Transforming the Business of Healthcare.

 

Learn more at www.thecranewaregroup.com (http://www.thecranewaregroup.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSSFEFFELSELW